iBio Inc (IBIO)
1.70
-0.07
(-3.95%)
USD |
NYAM |
Apr 19, 16:00
1.70
0.00 (0.00%)
After-Hours: 20:00
iBio Debt to Equity Ratio
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| September 30, 2023 | 0.9558 |
| June 30, 2023 | 0.8411 |
| March 31, 2023 | 0.7879 |
| December 31, 2022 | 0.8506 |
| September 30, 2022 | 0.459 |
| June 30, 2022 | 0.3491 |
| March 31, 2022 | 0.2787 |
| December 31, 2021 | 0.2434 |
| September 30, 2021 | 0.00 |
| June 30, 2021 | 0.0055 |
| March 31, 2021 | 0.0057 |
| December 31, 2020 | 0.0056 |
| September 30, 2020 | 0.0075 |
| June 30, 2020 | 0.0106 |
| March 31, 2020 | 0.3016 |
| December 31, 2019 | 0.00 |
| September 30, 2019 | 0.00 |
| June 30, 2019 | 0.00 |
| March 31, 2019 | 0.00 |
| December 31, 2018 | 0.00 |
| September 30, 2018 | 0.00 |
| June 30, 2018 | 0.00 |
| March 31, 2018 | 0.00 |
| December 31, 2017 | 0.00 |
| September 30, 2017 | 0.00 |
| Date | Value |
|---|---|
| June 30, 2017 | 0.00 |
| March 31, 2017 | 0.00 |
| December 31, 2016 | 0.00 |
| September 30, 2016 | 0.00 |
| June 30, 2016 | 0.00 |
| March 31, 2016 | 0.00 |
| December 31, 2015 | 0.00 |
| September 30, 2015 | 0.00 |
| June 30, 2015 | 0.00 |
| March 31, 2015 | 0.00 |
| December 31, 2014 | 0.00 |
| September 30, 2014 | 0.00 |
| June 30, 2014 | 0.00 |
| March 31, 2014 | 0.00 |
| December 31, 2013 | 0.00 |
| September 30, 2013 | 0.00 |
| June 30, 2013 | 0.00 |
| March 31, 2013 | 0.00 |
| December 31, 2012 | 0.00 |
| September 30, 2012 | 0.00 |
| June 30, 2012 | 0.00 |
| March 31, 2012 | 0.00 |
| December 31, 2011 | 0.00 |
| September 30, 2011 | 0.00 |
| June 30, 2011 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
Jun 2019
0.9558
Maximum
Sep 2023
0.2834
Average
0.127
Median
Debt to Equity Ratio Benchmarks
| Lixte Biotechnology Holdings Inc | -- |
| PAVmed Inc | -0.8211 |
| Avalo Therapeutics Inc | 0.00 |
| Imunon Inc | -- |
| Ocugen Inc | 0.069 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 34.02M |
| Total Liabilities (Quarterly) | 24.82M |
| Shareholders Equity (Quarterly) | 9.197M |